ACLX stock news
This page provides real-time market news, earnings updates, and company announcements related to Arcellx, Inc. (ACLX).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-15 07:24 EST
Arcellx (ACLX) Shares Encouraging Data on Latest Laboratory Study
Finviz2026-02-16 17:24:49
Arcellx surges over 76% in pre-market trading
格隆汇2026-02-23 11:12:55
Gilead Buys Arcellx To Fast-Track Next-Gen Myeloma Drug
Finviz2026-02-23 12:54:50
Global News You Need to Know Before the U.S. Stock Market Opens on Monday
华尔街见闻2026-02-23 13:56:42
Wells Fargo has recently downgraded its investment rating for cell therapy company ARCELLX, INC. from "Overweight" to "Equal Weight".
老虎证券2026-02-24 10:53:14
Gilead Snaps Up Arcellx For $115 Per Share - A $7.8 Billion Bet On Cancer Therapy
Finviz2026-02-25 15:13:01
Gilead to Acquire Arcellx, Inc. (ACLX) for Up to $7.8 billion
Finviz2026-03-10 07:36:48
Wells Fargo has recently downgraded its investment rating for cell therapy company ARCELLX, INC. from "Overweight" to "Equal Weight".
老虎证券2026-02-24 10:53:14
Gilead Snaps Up Arcellx For $115 Per Share - A $7.8 Billion Bet On Cancer Therapy
Finviz2026-02-25 15:13:01
Gilead to Acquire Arcellx, Inc. (ACLX) for Up to $7.8 billion
Finviz2026-03-10 07:36:48
ACLX stock chart
ACLX stock detailsACLX stock price change
On the last trading day, ACLX stock closed at 114.87 USD, with a price change of 0.03% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more